{"id":"xylose","rwe":[{"pmid":"41901821","year":"2026","title":"Optimized Alkaline Hydrolysis for Recovering Ferulated Arabinoxylan Biopolymers from Maize Bran with Antioxidant Functionality.","finding":"","journal":"Polymers","studyType":"Clinical Study"},{"pmid":"41901453","year":"2026","title":"β-Xylosidase Overexpression Alters Pectin and Cellulose Distribution and Modulates Blast Disease Resistance in Rice.","finding":"","journal":"Plants (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41900445","year":"2026","title":"The Effects of Applied Potential and Carbon Donor on Succinic Acid Production via Electro-Fermentation.","finding":"","journal":"Microorganisms","studyType":"Clinical Study"},{"pmid":"41900297","year":"2026","title":"Engineering of Escherichia coli for Co-Production of Lignocellulosic Ethanol and Poly(3-hydroxybutyrate).","finding":"","journal":"Microorganisms","studyType":"Clinical Study"},{"pmid":"41899844","year":"2026","title":"Valorization of Dried Okara Hydrolysate for Polyhydroxybutyrate Production by Newly Isolated Burkholderia sp. EP10.","finding":"","journal":"Bioengineering (Basel, Switzerland)","studyType":"Clinical Study"}],"tags":[{"label":"xylose","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Lyne","category":"company"},{"label":"Approved 1980s","category":"decade"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Lyne","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=XYLOSE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:45:34.830134+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:45:43.799410+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=XYLOSE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:45:44.544661+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236821/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:45:45.014910+00:00"}},"allNames":"wood sugar","offLabel":[],"synonyms":["xylose","wood sugar","(+)-xylose"],"timeline":[{"date":"1987-03-26","type":"positive","source":"DrugCentral","milestone":"FDA approval (Lyne)"}],"aiSummary":"Wood Sugar (XYLOSE) is a small molecule drug developed by LYNE, which remains under the company's ownership. It belongs to the xylose class and was approved by the FDA in 1987. The commercial status of Wood Sugar is off-patent, with no active Orange Book patents. However, there are no generic manufacturers available. As a result, the drug's availability and pricing may be limited.","approvals":[{"date":"1987-03-26","orphan":false,"company":"LYNE","regulator":"FDA"}],"brandName":"Wood Sugar","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"xylose","explanation":"","oneSentence":"","technicalDetail":"Xylose is a pentose sugar that is absorbed in the small intestine and then transported to the liver, where it is either used for energy production or converted into other sugars and amino acids."},"commercial":{"launchDate":"1987","_launchSource":"DrugCentral (FDA 1987-03-26, LYNE)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2854","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=XYLOSE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=XYLOSE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T16:10:31.065538","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:45:46.899565+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"xylose","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT05402345","phase":"PHASE2","title":"A Study of GlcNAc on Tear Production in NGLY1-CDDG","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eva Morava-Kozicz","startDate":"2025-01-24","conditions":["NGLY1 Deficiency"],"enrollment":18,"completionDate":"2026-12"},{"nctId":"NCT03024775","phase":"NA","title":"Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity","status":"RECRUITING","sponsor":"University of Palermo","startDate":"2017-01-01","conditions":["Non-celiac Wheat Sensitivity"],"enrollment":50,"completionDate":"2026-12-01"},{"nctId":"NCT01762579","phase":"NA","title":"Bio-markers of Not-celiac Wheat Sensitivity","status":"RECRUITING","sponsor":"University of Palermo","startDate":"2012-01-01","conditions":["Not-celiac Wheat Sensitivity"],"enrollment":100,"completionDate":"2026-12-01"},{"nctId":"NCT05136092","phase":"NA","title":"A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-02-16","conditions":["Colorectal Tumors"],"enrollment":12,"completionDate":"2024-09-27"},{"nctId":"NCT06044389","phase":"","title":"Observational Study on the Safety and Efficacy of the Medical Product Fructosin.","status":"UNKNOWN","sponsor":"Sciotec Diagnostic Technologies GmbH","startDate":"2023-10","conditions":["Fructose Intolerance"],"enrollment":60,"completionDate":"2024-08"},{"nctId":"NCT03243994","phase":"NA","title":"Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale","status":"COMPLETED","sponsor":"Jens Rikardt Andersen","startDate":"2016-02-01","conditions":["Chronic Obstructive Pulmonary Disease","Cor Pulmonale"],"enrollment":14,"completionDate":"2016-10-01"},{"nctId":"NCT02314455","phase":"NA","title":"Esophageal Absorption in EoE","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2014-09","conditions":["Eosinophilic Esophagitis"],"enrollment":14,"completionDate":"2016-07"},{"nctId":"NCT02654301","phase":"NA","title":"Beneficial Effect of Xylose Consumption on Postprandial Hyperglycemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-06","conditions":["Postprandial Hyperglycemia"],"enrollment":80,"completionDate":"2015-02"},{"nctId":"NCT01762566","phase":"NA","title":"Bioelectrical Impedance Analysis of Not-celiac Wheat Sensitivity Patients","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2012-01","conditions":["Not-celiac Gluten (Wheat) Sensitivity"],"enrollment":30,"completionDate":"2013-12"},{"nctId":"NCT01957098","phase":"NA","title":"The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2006-10","conditions":["Insulin Resistance"],"enrollment":14,"completionDate":"2007-05"},{"nctId":"NCT01324895","phase":"","title":"Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing","status":"COMPLETED","sponsor":"University of Florida","startDate":"2010-08","conditions":["Small Intestinal Bacterial Overgrowth Syndrome (SIBO)","Small Bowel Bacterial Overgrowth Syndrome (SBBOS)"],"enrollment":944,"completionDate":"2012-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000146456","MMSL":"4961","NDDF":"001145","UNII":"A1TA934AKO","VUID":"4018118","CHEBI":"CHEBI:18222","VANDF":"4018118","RXNORM":"11378","UMLSCUI":"C0043375","chemblId":"CHEMBL1236821","ChEMBL_ID":"CHEMBL502135","KEGG_DRUG":"D06346","DRUGBANK_ID":"DB09419","PDB_CHEM_ID":" HSY","PUBCHEM_CID":"135191","SNOMEDCT_US":"109193004","MESH_DESCRIPTOR_UI":"D014994"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1987-","companyName":"Lyne","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.2 hours","clearance":"2.38 mL/min/kg","volumeOfDistribution":"0.23 L/kg"},"publicationCount":16151,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"originalDeveloper":"Lyne","recentPublications":[{"date":"2026 Mar 12","pmid":"41901821","title":"Optimized Alkaline Hydrolysis for Recovering Ferulated Arabinoxylan Biopolymers from Maize Bran with Antioxidant Functionality.","journal":"Polymers"},{"date":"2026 Mar 18","pmid":"41901453","title":"β-Xylosidase Overexpression Alters Pectin and Cellulose Distribution and Modulates Blast Disease Resistance in Rice.","journal":"Plants (Basel, Switzerland)"},{"date":"2026 Mar 18","pmid":"41900445","title":"The Effects of Applied Potential and Carbon Donor on Succinic Acid Production via Electro-Fermentation.","journal":"Microorganisms"},{"date":"2026 Feb 26","pmid":"41900297","title":"Engineering of Escherichia coli for Co-Production of Lignocellulosic Ethanol and Poly(3-hydroxybutyrate).","journal":"Microorganisms"},{"date":"2026 Mar 9","pmid":"41899844","title":"Valorization of Dried Okara Hydrolysate for Polyhydroxybutyrate Production by Newly Isolated Burkholderia sp. EP10.","journal":"Bioengineering (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Lyne","companyId":"lyne","modality":"Small molecule","firstApprovalDate":"1987","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-03-26T00:00:00.000Z","mah":"LYNE","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:45:46.899565+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}